Axinn Attorneys Win 2021 Antitrust Writing Awards
June 30, 2021
Axinn is pleased to announce that the below articles authored or co-authored by Axinn lawyers have won a 2021 Concurrences Antitrust Writing award.
- Business Article (Cross-border Issues subcategory): "Do You Have to Put Up With That? Legal Protections in the Context of Antitrust Law Investigations in the U.S. and E.U.," Nicholas Gaglio, Lindsey Strang, Susan Zhu, Dr. Lukas Aberle and Dr. Christian Steinle, Compliance Berater (April 28, 2020) (English publication pending)
- Business Article (Intellectual Property subcategory): "Antitrust Treatment of Acceleration Provisions in Hatch-Waxman Settlements," Michael Keeley and Cristina Fernandez, FDLI’s Update Magazine (Winter 2020)
- Business Article (Mergers subcategory): "Another Way to Skin the Cat? Perspectives on Using Section 2 to Challenge the Acquisition of Nascent Competitors," Jimmy Moore and Timothy Snyder, The Threshold (Fall 2020)
The decisions were the result of a five-month process involving more than 50 international antitrust experts reviewing more than 600 articles. All winners were announced on June 30 at a virtual reception.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust